Daptomycin Lactated Ringer Biofilm Catheter Salvage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Central venous catheters (CVCs) are prone to biofilm formation, particularly with S. epidermidis, which is difficult to treat due to stationary phase bacteria and biofilm penetration challenges, leading to persistent infections.
Innovation Solution
Daptomycin formulations, particularly in lactated Ringer's solution, are used for biofilm treatment and catheter salvage, offering rapid bactericidal activity and effective penetration into biofilms, including stationary phase bacteria, through infusion and lock therapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat CVC biofilm infections, then treatment is attempted, but the treatment fails due to inability to penetrate biofilm and kill stationary phase bacteria
Solution Approach 1:
The patent changes the chemical parameters of the antibiotic by formulating daptomycin with specific surfactants and co-solvents, and by adjusting pH and ionic strength, to enable penetration through the biofilm matrix and effective killing of stationary phase bacteria
Solution Approach 2:
The patent uses surfactants and co-solvents as intermediary substances that facilitate the penetration of daptomycin through the hydrophobic biofilm matrix, acting as mediators between the antibiotic and the stationary phase bacteria within the biofilm
2Reliability
If daptomycin is formulated in saline solution, then administration is simple, but efficacy is reduced compared to lactated Ringer's solution formulations
Solution Approach 1:
The patent changes the physiological parameters of the formulation by using lactated Ringer's solution instead of saline, providing calcium ions and lactate that enhance daptomycin's bactericidal activity against stationary phase bacteria in biofilms
Solution Approach 2:
The patent creates a composite formulation combining daptomycin with lactated Ringer's solution, surfactants, and co-solvents to achieve synergistic effects that enhance penetration and killing activity while maintaining clinical usability
3Speed
If rapid bactericidal activity is achieved against stationary phase bacteria, then biofilm penetration must be effective, but this requires specialized formulations beyond standard antibiotic administration
Solution Approach 1:
The patent optimizes physical and chemical parameters including pH, ionic strength, surfactant concentration, and co-solvent ratios to achieve rapid bactericidal activity while maintaining formulation stability and clinical applicability
Solution Approach 2:
The patent employs surfactants and co-solvents as intermediary agents that rapidly facilitate daptomycin penetration into the biofilm matrix, enabling quick killing of stationary phase bacteria without requiring complex delivery devices
Data Source
AI summary
Daptomycin can be used for biofilm treatment (particularly central venous catheter salvage for S. epidermidis infected catheters). Catheter salvage with daptomycin shows rapid cidality, activity against stationary phase bacteria, and penetration and activity in biofilms. The present inventions provide formulations, methods, and articles of manufacture useful for biofilm treatment or catheter salvage involving daptomycin. Particular formulations include daptomycin in lactated Ringer's solution having a rapid kill curve against the bacteria of the biofilm.